ICABF yields 285714.29% · JNJ yields 2.13%● Live data
📍 ICABF pulled ahead of the other in Year 1
Combined, ICABF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ICABF + JNJ for your $10,000?
i-CABLE Communications Limited, an investment holding company, provides integrated communications services in Hong Kong. The company operates through Media and Telecommunications segments. The Media segment offers television subscription, domestic free television program, advertising, channel carriage, television relay, program licensing, theatrical release, and other related services. The Telecommunications segment includes operations related to broadband internet access, portal operations, telephony, network leasing, network construction, and mobile agency services, as well as other related businesses. The company owns and operates wireline telecommunications network, which provides media and telecommunications services to approximately two million households. The company also produces television and multimedia content focusing on news, information, sports, and entertainment. In addition, it provides technical services; and film production, distribution, and licensing services. The company was incorporated in 1999 and is based in Tsuen Wan, Hong Kong.
Full ICABF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.